A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

The detection rate of thyroid cancer (PTC) has increased rapidly in recent years. Except undifferentiated cancer, surgery is still one of the most important treatments for all types of thyroid cancer, and there is a consensus to use the lobes of the gland as the minimum extent of resection. In the meantime, a basic consensus has been reached that central zone lymph node (VI) dissection is the minimum extent of lymph node dissection. In clinical practice, neck surgery and lumpectomy are mostly performed. Hypoparathyroidism and recurrent laryngeal nerve injury are the most common complications o

Trial Details

NCT ID
NCT06791005
Phase
PHASE3
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Status
RECRUITING
Cancer Type
Papillary Thyroid Cancer
Interventions
  • Preoperative Injection of Carbon Nanoparticles
  • Intraoperative Injection of Carbon Nanoparticles
Locations (sample)
  • Xi'an, Shaanxi, China|34.25833,108.92861

Key Eligibility Criteria

  • Preoperative pathological assessment indicated the presence of thyroid cancer with a maximum diameter of less than 4 cm.
  • Postoperative pathological evaluation confirmed bilateral thyroid cancer or lateral lymph node metastasis.
  • Vocal cord examination conducted one week prior to surgery revealed no abnormalities.
  • The patient had no history of prior thyroid surgery and required a total thyroidectomy.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Papillary Thyroid Cancer Trials on Trialify →